|
WO2010120897A1
|
|
Compositions and methods for modulating immunogenic responses by activating dendritic cells
|
|
US2009143457A1
|
|
Polycyclic compounds for use in treating ocular neurodegenerative diseases
|
|
US2010047920A1
|
|
Device improving the detection of a ligand
|
|
EP1613946A2
|
|
Self-contained assay device for rapid detection of biohazardous agents
|
|
US2006035984A1
|
|
Method of inhibiting formation of Neisseria gonorrhea and Neisseria meningiditis
|
|
US2002115213A1
|
|
Engraftable neural progenitor & stem cells for brain tumor therapy
|
|
AU8825001A
|
|
Methods for treating subjects infected with a herpes virus orneisseria gonorrheae
|
|
US7186409B2
|
|
Neural stem cells and use thereof for brain tumor therapy
|
|
US6197834B1
|
|
Method of inhibiting formation of infectious herpes virus particles
|
|
US5821057A
|
|
Assay for agents that affect cholesterol 7alpha-hydroxylase expression and a characterization of its regulatory elements
|
|
US6153427A
|
|
Erythropoietin-inducible, erythroid-specific DNA construct
|
|
EP0648841A2
|
|
Genomic DNA of human Cholesterol 7alpha-hydroxylase and methods for using it
|
|
EP0648840A2
|
|
Cholesterol 7alpha-hydroxylase gene regulatory elements and transcription factors.
|
|
US5558999A
|
|
Cholesterol 7α-hydroxylase gene regulatory elements and methods for using them
|
|
US5420028A
|
|
Truncated human cholesterol 7α-hydroxylase, method of production and use thereof
|
|
US5213803A
|
|
Antiviral composition and method
|
